CNI Cancer Evaluation Test
The Chronix Biomedical CNI Screen blood test is a vast improvement to more traditional methods of determining the presence of cancer. The essential difference is that now for the first time, using proprietary Next Generation Sequencing we can detect cancer mutations of DNA in blood plasma. Our method is based on years long development using proprietary technologies and sophisticated and detailed comparisons to our database of healthy individuals. This enables a sensitive and specific distinction of normal variances from cfDNA that is of high risk to be coming from a malignancy. Advantages of this new technology, are that we can now look at the entirety of the body and its health state relating to cancer. Current scanning and tissue biopsy can only look at a specific part of the body, such as the lung or prostate, and is usually only carried out on presentation of symptoms.